MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offe
Source: www.prnewswire.com
Boston Scientific Corp. (NYSE: BSX) recently announced the acquisition of BTG plc, headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases for $4.2 billion. BSX is a manufacturer of medical devices used in interventional medical specialities, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
